These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33234304)

  • 1. Next-generation rotavirus vaccine developers meeting: Summary of a meeting sponsored by PATH and the bill & melinda gates foundation (19-20 June 2019, Geneva).
    Fix A; Kirkwood CD; Steele D; Flores J
    Vaccine; 2020 Dec; 38(52):8247-8254. PubMed ID: 33234304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Challenges and Opportunities of Next-Generation Rotavirus Vaccines: Summary of an Expert Meeting with Vaccine Developers.
    Chen J; Grow S; Iturriza-Gómara M; Hausdorff WP; Fix A; Kirkwood CD
    Viruses; 2022 Nov; 14(11):. PubMed ID: 36423174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. National stakeholder preferences for next-generation rotavirus vaccines: Results from a six-country study.
    Price J; Mooney J; Bain C; Bawa JT; Gurley N; Kumar A; Liyanage G; Mkisi RE; Odero C; Seck K; Simpson E; Hausdorff WP
    Vaccine; 2022 Jan; 40(2):370-379. PubMed ID: 34863614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential impact and cost-effectiveness of injectable next-generation rotavirus vaccines in 137 LMICs: a modelling study.
    Debellut F; Pecenka C; Hausdorff WP; Clark A
    Hum Vaccin Immunother; 2022 Dec; 18(1):2040329. PubMed ID: 35240926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules.
    Clark A; Tate J; Parashar U; Jit M; Hasso-Agopsowicz M; Henschke N; Lopman B; Van Zandvoort K; Pecenka C; Fine P; Sanderson C
    Lancet Glob Health; 2019 Nov; 7(11):e1541-e1552. PubMed ID: 31607466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healthcare provider perspectives on delivering next generation rotavirus vaccines in five low-to-middle-income countries.
    Mooney J; Price J; Bain C; Bawa JT; Gurley N; Kumar A; Liyanage G; Mkisi RE; Odero C; Seck K; Simpson E; Hausdorff WP
    PLoS One; 2022; 17(6):e0270369. PubMed ID: 35737718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population effectiveness of the pentavalent and monovalent rotavirus vaccines: a systematic review and meta-analysis of observational studies.
    Hungerford D; Smith K; Tucker A; Iturriza-Gómara M; Vivancos R; McLeonard C; A Cunliffe N; French N
    BMC Infect Dis; 2017 Aug; 17(1):569. PubMed ID: 28810833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rotavirus vaccines: targeting the developing world.
    Glass RI; Bresee JS; Turcios R; Fischer TK; Parashar UD; Steele AD
    J Infect Dis; 2005 Sep; 192 Suppl 1():S160-6. PubMed ID: 16088799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rotavirus vaccination and intussusception - Science, surveillance, and safety: A review of evidence and recommendations for future research priorities in low and middle income countries.
    Yen C; Healy K; Tate JE; Parashar UD; Bines J; Neuzil K; Santosham M; Steele AD
    Hum Vaccin Immunother; 2016 Oct; 12(10):2580-2589. PubMed ID: 27322835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant use of an oral live pentavalent human-bovine reassortant rotavirus vaccine with licensed parenteral pediatric vaccines in the United States.
    Rodriguez ZM; Goveia MG; Stek JE; Dallas MJ; Boslego JW; DiNubile MJ; Heaton PM
    Pediatr Infect Dis J; 2007 Mar; 26(3):221-7. PubMed ID: 17484218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trials.
    Clark A; van Zandvoort K; Flasche S; Sanderson C; Bines J; Tate J; Parashar U; Jit M
    Lancet Infect Dis; 2019 Jul; 19(7):717-727. PubMed ID: 31178289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring indirect effects of rotavirus vaccine in low income countries.
    Bennett A; Bar-Zeev N; Cunliffe NA
    Vaccine; 2016 Aug; 34(37):4351-3. PubMed ID: 27443593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rotavirus vaccines: opportunities and challenges.
    Grimwood K; Lambert SB
    Hum Vaccin; 2009 Feb; 5(2):57-69. PubMed ID: 18838873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Neonatal Rotavirus Vaccine (RV3-BB) to Target Rotavirus from Birth.
    Bines JE; At Thobari J; Satria CD; Handley A; Watts E; Cowley D; Nirwati H; Ackland J; Standish J; Justice F; Byars G; Lee KJ; Barnes GL; Bachtiar NS; Viska Icanervilia A; Boniface K; Bogdanovic-Sakran N; Pavlic D; Bishop RF; Kirkwood CD; Buttery JP; Soenarto Y
    N Engl J Med; 2018 Feb; 378(8):719-730. PubMed ID: 29466164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs.
    Patel MM; Parashar UD
    J Infect Dis; 2009 Nov; 200 Suppl 1():S291-9. PubMed ID: 19817612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WHO informal consultation on quality, safety and efficacy specifications for live attenuated rotavirus vaccines Mexico City, Mexico, 8-9 February 2005.
    Wood D;
    Vaccine; 2005 Dec; 23(48-49):5478-87. PubMed ID: 16129525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outstanding challenges for rotavirus vaccine introduction in low-income countries--a systematic review.
    Ustrup M; Madsen LB; Bygbjerg IC; Konradsen F
    Dan Med Bull; 2011 Oct; 58(10):A4323. PubMed ID: 21975154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polio endgame: Lessons for the global rotavirus vaccination program.
    Jiang B; Patel M; Glass RI
    Vaccine; 2019 May; 37(23):3040-3049. PubMed ID: 31027927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rotavirus epidemiology and vaccine demand: considering Bangladesh chapter through the book of global disease burden.
    Mahmud-Al-Rafat A; Muktadir A; Muktadir H; Karim M; Maheshwari A; Ahasan MM
    Infection; 2018 Feb; 46(1):15-24. PubMed ID: 29047020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Research progress in rotavirus VP4 subunit vaccine].
    Jia L; Li T; Ge S
    Sheng Wu Gong Cheng Xue Bao; 2017 Jul; 33(7):1075-1084. PubMed ID: 28869727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.